Research ArticleBRAIN
Dynamic Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin
Soonmee Cha, Edmond A. Knopp, Glyn Johnson, Andrew Litt, Jon Glass, Michael L. Gruber, Stanley Lu and David Zagzag
American Journal of Neuroradiology May 2000, 21 (5) 881-890;
Soonmee Cha
Edmond A. Knopp
Glyn Johnson
Andrew Litt
Jon Glass
Michael L. Gruber
Stanley Lu

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Advertisement
Soonmee Cha, Edmond A. Knopp, Glyn Johnson, Andrew Litt, Jon Glass, Michael L. Gruber, Stanley Lu, David Zagzag
Dynamic Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin
American Journal of Neuroradiology May 2000, 21 (5) 881-890;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard
- Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications
- Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
- Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
- Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors
- MRI for assessing antivascular cancer treatments
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement